Subscribe
shutterstock_436917634_eqroy
EQroy / Shutterstock.com
8 October 2020Big PharmaMuireann Bolger

South Africa, India urge WTO to waive IP for COVID-19 treatments

South Africa and India have asked the World Trade Organization (WTO) to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.
Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Americas
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.
Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Americas
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

More on this story

Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.
Biotechnology
WTO fails to strike deal to waive COVID-19 IP
20 October 2020   Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.
Americas
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB